Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Hertel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Hepatology (Baltimore, Md.)|October 23, 2023
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver diseaseAndrew Wang, Amanda L Blackford, Cynthia Behling, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 3, 2024
Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severityMarialena Mouzaki, Katherine P Yates, Ana Catalina Arce-Clachar, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 12, 2025
Vibration-controlled transient elastography in pediatric metabolic dysfunction-associated steatotic liver diseaseLauren B Nichols, Sebastian G J Oakes, Cynthia Behling, et al.
Hepatology Communications|December 6, 2023
Nutrition assessment and MASH severity in children using the Healthy Eating IndexAjay Kumar Jain, Paula Buchannan, Katherine P Yates, et al.
Hepatology (Baltimore, Md.)|February 8, 2022
Randomized placebo-controlled trial of losartan for pediatric NAFLDMiriam B Vos, Mark L Van Natta, Niviann M Blondet, et al.
Plos One|April 15, 2022
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsTinsay A Woreta, Mark L Van Natta, Mariana Lazo, et al.
Hepatology (Baltimore, Md.)|September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver diseaseDaniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Hepatology (Baltimore, Md.)|October 23, 2023
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver diseaseAndrew Wang, Amanda L Blackford, Cynthia Behling, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 3, 2024
Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severityMarialena Mouzaki, Katherine P Yates, Ana Catalina Arce-Clachar, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 12, 2025
Vibration-controlled transient elastography in pediatric metabolic dysfunction-associated steatotic liver diseaseLauren B Nichols, Sebastian G J Oakes, Cynthia Behling, et al.
Hepatology Communications|December 6, 2023
Nutrition assessment and MASH severity in children using the Healthy Eating IndexAjay Kumar Jain, Paula Buchannan, Katherine P Yates, et al.
Hepatology (Baltimore, Md.)|February 8, 2022
Randomized placebo-controlled trial of losartan for pediatric NAFLDMiriam B Vos, Mark L Van Natta, Niviann M Blondet, et al.
Plos One|April 15, 2022
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsTinsay A Woreta, Mark L Van Natta, Mariana Lazo, et al.
Hepatology (Baltimore, Md.)|September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver diseaseDaniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Pageof 2